BUZZ - Hims & Hers quietly takes the lead ahead of White House meeting on peptide policy
路透社2026/10/23 14:52October 23 - ** Shares of telemedicine company Hims & Hers Health (HIMS.N) fell 4.5% to $27.82 after the White House scheduled a review meeting on policies regarding the formulation of peptide drugs today.
** According to the website of the Office of Information and Regulatory Affairs, the meeting proposed by Hims & Hers Health is scheduled for October 23 at 2:00 pm (U.S. Eastern Time).
** Last week, the U.S. Food and Drug Administration (FDA) submitted a policy amendment proposal to the White House for review (link), which, if approved, would make it easier for pharmacies to formulate certain peptide drugs.
** HIMS previously stated that if the regulations allowed, the company plans to offer peptide drugs (link).
** Earlier this week (link), U.S. Secretary of Health Robert F. Kennedy Jr. said the government aims to expand accessibility to peptide drugs by establishing a regulated market.
** As of the close of the previous trading day, the stock had declined by about 14% for the year to date.
(To assist non-native English speakers, Reuters has automatically translated its report into several other languages. As automated translations may contain errors or lack necessary context, Reuters does not guarantee the accuracy of the translated text. They are provided for reader convenience only. Reuters accepts no responsibility for any harm or loss arising from using the automated translation function.)
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Africa’s payment giant backed by SoftBank is rushing to list in the US! Opay (OPAY.US) plans to raise $336 million, with its valuation possibly exceeding $4 billion
The payment platform Opay Ltd., which focuses on the Nigerian market, plans to raise up to 336 million dollars through an initial public offering (IPO).
BMT surges past $0.039, briefly up over 40%
Western Digital (WDC.US) CFO refutes claims of AI demand peaking: No signs of weakening, if it cools down it could help us catch up with the demand gap
Western Digital's CFO expressed strong support for AI storage demand, stating that hyperscale cloud providers are continuously increasing capital expenditures and have engaged in discussions regarding supply needs through 2030 to 2031. Although the company's quarterly results exceeded expectations and profit guidance was raised, capital expenditure more than doubled compared to the same period last year, putting pressure on free cash flow. This has sparked concerns in the market about the sustainability of returns on AI data center investments. The stock closed down by about 3% on Friday.
Crypto prices
More
